China NT Pharma Group Company Limited (HKG:1011)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.730
0.00 (0.00%)
At close: Mar 10, 2026
259.61%
Market Cap 492.20M
Revenue (ttm) 20.45M
Net Income (ttm) -77.72M
Shares Out 674.25M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 70,000
Average Volume 242,190
Open 0.730
Previous Close 0.730
Day's Range 0.730 - 0.730
52-Week Range 0.193 - 1.350
Beta -2.29
RSI 37.05
Earnings Date Nov 7, 2025

About HKG:1011

China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China. It operates through Digital Services and Sales Agency Service segments. The company acts as agent for clients to sell medical and health-related products to external customers. It also provides marketing and promotion in relation to bone health knowledge. In addition, the company is involved in trading of prescription medicines... [Read more]

Sector Healthcare
Founded 1995
Employees 21
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1011
Full Company Profile

Financial Performance

In 2024, HKG:1011's revenue was 37.96 million, an increase of 415.34% compared to the previous year's 7.37 million. Losses were -53.36 million, -62.84% less than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.